CYTH logo

Cyclo Therapeutics (CYTH) Gross Margin

Annual Gross Margin

92.16%
+2.26%+2.51%

December 31, 2023

Summary

Performance

1-Year Change

+2.51%

3-Year Change

-0.53%

5-Year Change

+2.83%

15-Year Change

+3.25%

CYTH Gross Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

93.72%
CYTH annual gross profit margin is higher than 93.72% of companies in Healthcare sector

High & Low

All-time High

92.65%
CYTH annual gross profit margin is currently -0.53% below its historical high of 92.65%

3-Year Low

89.90%
CYTH annual gross profit margin is currently +2.51% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CYTH previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 18, 2025
CYTH next annual earnings announcement is scheduled for Mar 18, 2025

OtherCYTHprofitabilitymetrics:

Annual Revenue

$1.08 M
CYTH annual revenue is $1.08 million

Annual Gross Profit

$992.00 K
CYTH annual gross profit is $992.00 thousand

Annual Operating Margin

-1862.69%
CYTH annual operating profit margin is -1862.69%

Annual Net Margin

-1863.36%
CYTH annual net profit margin is -1863.36%

Quarterly Gross Margin

92.81%
+3.68%+4.13%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

-2.33%

3-Year Change

-2.33%

5-Year Change

-2.33%

CYTH Quarterly Gross Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

93.18%
CYTH quarterly gross profit margin is higher than 93.18% of companies in Healthcare sector

High & Low

All-time High

105.48%
CYTH quarterly gross profit margin is currently -12.01% below its historical high of 105.48%

3-Year Low

83.00%
CYTH quarterly gross profit margin is currently +11.82% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CYTH previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 18, 2025
CYTH next earnings announcement is scheduled for Mar 18, 2025

OtherCYTHprofitabilitymetrics:

Quarterly Revenue

$233.80 K
CYTH quarterly revenue is $233.80 thousand

Quarterly Gross Profit

$217.00 K
CYTH quarterly gross profit is $217.00 thousand

Quarterly Operating Margin

-3545.95%
CYTH quarterly operating profit margin is -3545.95%

Quarterly Net Margin

-3778.44%
CYTH quarterly net profit margin is -3778.44%

Gross Margin Formula

Gross Margin =  Gross Profit
Revenue ✕ 100%

Annual Gross Margin

92.16%
CYTH annual gross profit margin is 92.16%

Annual Gross Profit

$992.00 K
CYTH annual gross profit is $992.00 thousand

Annual Revenue

$1.08 M
CYTH annual revenue is $1.08 million

CYTH Gross Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+2.5%-2.3%
3 y3 years-0.5%-2.3%
5 y5 years+2.8%-2.3%

CYTH Gross Margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+2.5%-2.3%+11.8%
5 y5-year-0.5%+2.5%-2.3%+11.8%
alltimeall time-0.5%+25.4%-12.0%+80.1%

Cyclo Therapeutics Gross Margin History

DateAnnualQuarterly
Sep 2024
-
92.81%(+4.1%)
Jun 2024
-
89.13%(-5.3%)
Mar 2024
-
94.16%(-0.9%)
Dec 2023
92.16%(+2.5%)
95.02%(+3.1%)
Sep 2023
-
92.18%(+11.1%)
Jun 2023
-
83.00%(-11.0%)
Mar 2023
-
93.31%(+1.9%)
Dec 2022
89.90%(-0.3%)
91.56%(-1.2%)
Sep 2022
-
92.69%(+7.3%)
Jun 2022
-
86.41%(-5.6%)
Mar 2022
-
91.55%(+3.7%)
Dec 2021
90.16%(-2.7%)
88.27%(-6.5%)
Sep 2021
-
94.39%(+8.0%)
Jun 2021
-
87.36%(-3.3%)
Mar 2021
-
90.34%(+1.1%)
Dec 2020
92.65%(+0.2%)
89.39%(-5.7%)
Sep 2020
-
94.80%(+1.0%)
Jun 2020
-
93.82%(+2.1%)
Mar 2020
-
91.89%(-2.7%)
Dec 2019
92.50%(+3.2%)
94.43%(+3.9%)
Sep 2019
-
90.92%(-3.3%)
Jun 2019
-
94.03%(+3.7%)
Mar 2019
-
90.69%(-3.6%)
Dec 2018
89.62%(+0.4%)
94.04%(-0.2%)
Sep 2018
-
94.19%(+11.4%)
Jun 2018
-
84.53%(-4.0%)
Mar 2018
-
88.05%(-3.4%)
Dec 2017
89.26%(+2.8%)
91.18%(-0.7%)
Sep 2017
-
91.85%(+8.2%)
Jun 2017
-
84.89%(-9.4%)
Mar 2017
-
93.65%(+9.1%)
Dec 2016
86.80%(-0.1%)
85.87%(-3.4%)
Sep 2016
-
88.90%(+4.1%)
Jun 2016
-
85.39%(-3.2%)
Mar 2016
-
88.22%(+0.2%)
Dec 2015
86.91%(+5.2%)
88.08%(-1.3%)
Sep 2015
-
89.25%(+5.1%)
Jun 2015
-
84.91%(-2.4%)
Mar 2015
-
87.03%(+23.4%)
Dec 2014
82.61%(+10.4%)
70.53%(-19.9%)
Sep 2014
-
88.04%(+1.5%)
Jun 2014
-
86.77%(+10.5%)
Mar 2014
-
78.51%(-7.4%)
Dec 2013
74.84%(-13.6%)
84.80%(+2.7%)
Sep 2013
-
82.61%(+4.0%)
Jun 2013
-
79.46%(+26.1%)
Mar 2013
-
63.01%(-40.3%)
Dec 2012
86.63%
105.48%(+23.7%)
DateAnnualQuarterly
Sep 2012
-
85.25%(+1.1%)
Jun 2012
-
84.32%(+12.1%)
Mar 2012
-
75.21%(-20.1%)
Dec 2011
73.47%(-14.3%)
94.15%(+12.0%)
Sep 2011
-
84.10%(+63.2%)
Jun 2011
-
51.54%(-36.6%)
Mar 2011
-
81.26%(-4.8%)
Dec 2010
85.71%(+4.2%)
85.35%(+2.7%)
Sep 2010
-
83.12%(-7.1%)
Jun 2010
-
89.46%(+4.9%)
Mar 2010
-
85.26%(+11.7%)
Dec 2009
82.24%(+2.9%)
76.35%(-6.6%)
Sep 2009
-
81.78%(-5.5%)
Jun 2009
-
86.52%(-0.1%)
Mar 2009
-
86.62%(+1.4%)
Dec 2008
79.93%(-5.1%)
85.41%(-12.7%)
Sep 2008
-
97.81%(+61.6%)
Jun 2008
-
60.53%(-13.5%)
Mar 2008
-
70.00%(+0.1%)
Dec 2007
84.24%(+9.5%)
69.95%(-12.4%)
Sep 2007
-
79.89%(-14.1%)
Jun 2007
-
93.04%(-5.6%)
Mar 2007
-
98.58%(+10.4%)
Dec 2006
76.92%(-9.9%)
89.27%(+25.4%)
Sep 2006
-
71.21%(+1.4%)
Jun 2006
-
70.22%(-7.5%)
Mar 2006
-
75.89%(+3.7%)
Dec 2005
85.33%(+2.8%)
73.20%(-15.9%)
Sep 2005
-
87.04%(-4.5%)
Jun 2005
-
91.16%(+6.9%)
Mar 2005
-
85.26%(+2.9%)
Dec 2004
83.04%(-6.1%)
82.87%(+6.7%)
Sep 2004
-
77.64%(-13.6%)
Jun 2004
-
89.81%(+8.9%)
Mar 2004
-
82.46%(-11.5%)
Dec 2003
88.48%(+5.5%)
93.21%(+3.9%)
Sep 2003
-
89.69%(+11.1%)
Jun 2003
-
80.76%(-4.2%)
Mar 2003
-
84.33%(+9.4%)
Dec 2002
83.83%(-5.0%)
77.11%(-16.7%)
Sep 2002
-
92.59%(+15.3%)
Jun 2002
-
80.31%(-2.2%)
Mar 2002
-
82.08%(+3.0%)
Dec 2001
88.24%(+6.0%)
79.71%(-13.4%)
Sep 2001
-
92.00%(-0.8%)
Jun 2001
-
92.70%(+6.9%)
Mar 2001
-
86.72%(+14.4%)
Dec 2000
83.23%
75.83%(-18.2%)
Sep 2000
-
92.71%

FAQ

  • What is Cyclo Therapeutics annual gross profit margin?
  • What is the all time high annual gross margin for Cyclo Therapeutics?
  • What is Cyclo Therapeutics annual gross margin year-on-year change?
  • What is Cyclo Therapeutics quarterly gross profit margin?
  • What is the all time high quarterly gross margin for Cyclo Therapeutics?
  • What is Cyclo Therapeutics quarterly gross margin year-on-year change?

What is Cyclo Therapeutics annual gross profit margin?

The current annual gross margin of CYTH is 92.16%

What is the all time high annual gross margin for Cyclo Therapeutics?

Cyclo Therapeutics all-time high annual gross profit margin is 92.65%

What is Cyclo Therapeutics annual gross margin year-on-year change?

Over the past year, CYTH annual gross profit margin has changed by +2.26% (+2.51%)

What is Cyclo Therapeutics quarterly gross profit margin?

The current quarterly gross margin of CYTH is 92.81%

What is the all time high quarterly gross margin for Cyclo Therapeutics?

Cyclo Therapeutics all-time high quarterly gross profit margin is 105.48%

What is Cyclo Therapeutics quarterly gross margin year-on-year change?

Over the past year, CYTH quarterly gross profit margin has changed by -2.21% (-2.33%)